477 results on '"I. Chau"'
Search Results
2. BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)
3. Iron scavenging and suppression of collagen cross-linking underlie antifibrotic effects of carnosine in the heart with obesity
4. CN45 The Gastrointestinal and Lymphoma Unit Advanced Nurse Practitioner role in clinical research at The Royal Marsden Hospital
5. 1253P Safety and efficacy of Wnt inhibition with a DKK1 inhibitor, DKN-01, in combination with atezolizumab in patients with advanced oesophagogastric adenocarcinoma: Phase IIa results of the WAKING trial
6. 87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience
7. O-3 Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): Expanded efficacy and safety analyses from CheckMate 648
8. 1205MO Updated analysis of DESTINY-Gastric02: A phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable/metastatic gastric/gastroesophageal junction (GEJ) cancer who progressed on or after trastuzumab-containing regimen
9. 633P Determining the prognostic value of end of treatment (EOT) 18F-choline positron emission tomography (PET) in patients treated with primary central nervous system lymphoma (PCNSL) who respond to first-line therapy: A single centre retrospective study at the Royal Marsden Hospital (RMH)
10. Corrigendum to 'Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'
11. PD-2 EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma
12. SO-9 Pathological primary tumour and lymph node regression following neoadjuvant chemotherapy in resectable oesophagogastric cancer: Pooled analysis of 1619 patients from two randomised trials
13. 1386P Phase II study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (pembro) in advanced gastric or gastroesophageal junction (GEJ) cancer
14. 1446P Initial safety and efficacy findings with bavituximab plus pembrolizumab in patients with advanced gastric or gastroesophageal cancer
15. Caregiving burden among informal caregivers of people with disability
16. Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies
17. Gastric Cancer - From Aetiology to Management: Differences Between the East and the West
18. Experimental study of as-built and composite materials retrofitted reinforced concrete columns
19. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
20. Quality-of-life (QoL) results from RAINFALL: A randomized, double-blind, placebo (PL)-controlled phase III study of cisplatin (Cis) plus capecitabine (Cape) or 5FU with or without ramucirumab (RAM) as first-line therapy for metastatic gastric or gastroesophageal junction (G-GEJ) cancer
21. The lateral load-deformation response of RC walls with a consideration of the height–length ratio
22. Neoadjuvant folfirinox in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis
23. Life-cycle cost analysis in determining an importance factor for fire department buildings
24. Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer
25. Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer
26. MORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types
27. Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Patient reported outcome results across two phase III studies (REACH-2 and REACH)
28. EGFR amplification (amp) and survival in the REAL-3 trial
29. Application of Normalized Spectral Acceleration-Displacement (NSAD) Format on Performance-Based Seismic Design of Bridge Structures
30. The Timed-up-and-go (TUG) Test: Illustrative Case Presentation to Demonstrate Its Relation to Pain, Functional Disability, and Health-Related Quality of Life in Patients with Lumbar Degenerative Disc Disease
31. Correlation of Pain, Functional Disability, and Health-Related Quality of Life with Radiological Grading Scales for Lumbar Degenerative Disc Disease
32. Gender Differences in Subjective and Objective Measures for Patients with Lumbar Degenerative Disc Disease
33. Validity and Reliability of an Objective Measurement of Functional Impairment in Lumbar Degenerative Spine Disease: The Timed-Up-and-Go (TUG) Test
34. Performance‐based damage assessment of low‐rise reinforced concrete buildings
35. A study on pushover analyses of reinforced concrete columns
36. Experimental study of as-built and composite materials retrofitted reinforced concrete columns
37. Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
38. Genetic variation between hybrid (Labeo rohita ♂, Cirrhinus mrigala ♀ and Labeo rohita) by RAPD marker
39. Culturally adapted psychoeducation for bipolar disorder in a low-resource setting: protocol for a multicentre randomized controlled trial
40. Measurement-based care vs. standard care for major depressive disorder in Pakistan: protocol for a randomized control trial
41. Functional magnetic resonance (fMR) imaging of a rat brain tumor model: implications for evaluation of tumor microvasculature and therapeutic response
42. [Untitled]
43. The lateral load-deformation response of RC walls with a consideration of the height–length ratio
44. Old and New Therapies for GEP NETs
45. Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI
46. Response of multi-degree-of-freedom structures with sliding supports
47. Impedance control of a teleoperated mini excavator
48. An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma
49. HFSM-Based Software Implementation of Haptic Interactions
50. Life-cycle cost analysis in determining an importance factor for fire department buildings
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.